Skip to content

Author

Paweł Mikołajczak

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Anti-CD20 MONOCLONAL ANTIBODIES IN THE TREATMENT OF MULTIPLE SCLEROSIS: MECHANISMS OF ACTION, CLINICAL EFFICACY, SAFETY, AND CONTEMPORARY THERAPEUTIC PERSPECTIVES

Multiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system in which B lymphocytes play a central role in disease pathogenesis. The development of anti-CD20 monoclonal antibodies has transformed the therapeutic landscape of MS by providing highly effective disease-modifying therapies with...

Mateusz Kałwik, Iga Klepacz, Paweł Mikołajczak et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.